Neuromodulation

Karen Noblett; Carly Crowder

doi:10.1016/j.ogc.2021.05.018

Neuromodulation

Obstet Gynecol Clin North Am. 2021 Sep;48(3):677-688. doi: 10.1016/j.ogc.2021.05.018.

Authors

Karen Noblett¹, Carly Crowder²

Affiliations

¹ Department of Obstetrics & Gynecology, University of California, Irvine, 101 The City Drive South, Orange, CA 92686, USA. Electronic address: knoblett@axonics.com.
² Department of Obstetrics & Gynecology, University of California, Irvine, 101 The City Drive South, Orange, CA 92686, USA.

PMID: 34416945
DOI: 10.1016/j.ogc.2021.05.018

Abstract

Sacral neuromodulation (SNM) has been available in the United States for more than 20 years and is a guideline-recommended therapy by both the American Urological Association and the American Society of Colon and Rectal Surgeons, with proven long-term success for urinary urgency incontinence, urinary urgency frequency, nonobstructive urinary retention, and fecal incontinence. Initially the therapy involved a more invasive surgical approach that included a large cut down over the sacrum. This article reviews recent advancements in SNM therapy including updates in best practices for implant technique, technological innovations, and the new clinical literature relevant to contemporary practice.

Keywords: Axonics; Fecal incontinence; InterStim; Sacral neuromodulation; Urinary retention; Urinary urgency incontinence.

Publication types

Review

MeSH terms

Electric Stimulation Therapy*
Fecal Incontinence* / therapy
Humans
Sacrum
Treatment Outcome
Urinary Incontinence*